Cargando…

Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion

Mycobacterium tuberculosis (Mtb) genetic micro-diversity in clinical isolates may underline mycobacterial adaptation to tuberculosis (TB) infection and provide insights to anti-TB treatment response and emergence of resistance. Herein we followed within-host evolution of Mtb clinical isolates in two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Genestet, Charlotte, Hodille, Elisabeth, Barbry, Alexia, Berland, Jean-Luc, Hoffmann, Jonathan, Westeel, Emilie, Bastian, Fabiola, Guichardant, Michel, Venner, Samuel, Lina, Gérard, Ginevra, Christophe, Ader, Florence, Goutelle, Sylvain, Dumitrescu, Oana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224949/ https://www.ncbi.nlm.nih.gov/pubmed/34166469 http://dx.doi.org/10.1371/journal.ppat.1009643

Ejemplares similares

Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction
por: Bahuaud, Olivier, et al.
Publicado: (2022)

Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017–2018
por: Genestet, Charlotte, et al.
Publicado: (2019)

Consistency of Mycobacterium tuberculosis Complex Spoligotyping between the Membrane-Based Method and In Silico Approach
por: Genestet, Charlotte, et al.
Publicado: (2022)

Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory
por: Genestet, Charlotte, et al.
Publicado: (2022)

The MTB/MDR ELITe MGB(®) Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center
por: Hodille, Elisabeth, et al.
Publicado: (2021)

Assessment of closely related Mycobacterium tuberculosis variants with different transmission success and in vitro infection dynamics
por: Abascal, Estefanía, et al.
Publicado: (2021)

A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells—using rifampicin as an example
por: Clewe, Oskar, et al.
Publicado: (2015)

Changing patterns of human migrations shaped the global population structure of Mycobacterium tuberculosis in France
por: Barbier, Maxime, et al.
Publicado: (2018)

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
por: Grard, Soazic, et al.
Publicado: (2015)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Rapid, Easy, and Reliable Identification of Nocardia sp. by MALDI-TOF Mass Spectrometry, VITEK(®)-MS IVD V3.2 Database, Using Direct Deposit
por: Hodille, Elisabeth, et al.
Publicado: (2023)

Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus
por: Hodille, Elisabeth, et al.
Publicado: (2022)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion
por: Chedid, Carole, et al.
Publicado: (2022)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Staphylococcal Panton–Valentine Leucocidin and Gamma Haemolysin Target and Lyse Mature Bone Marrow Leucocytes
por: Hodille, Elisabeth, et al.
Publicado: (2020)

Mycobacterium tuberculosis Diversity Exploration: A Way to Serve the Three Main Weapons against Epidemics, Hygiene, Vaccine Development and Chemotherapy
por: Refrégier, Guislaine, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Benzo[b]thiophene Acylhydrazones as Antimicrobial Agents against Multidrug-Resistant Staphylococcus aureus
por: Barbier, Thibaut, et al.
Publicado: (2022)

Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
por: Patel, Yesha S., et al.
Publicado: (2017)

The Synergistic Effect of Exogenous Glutamine and Rifampicin Against Mycobacterium Persisters
por: Huang, Xue, et al.
Publicado: (2018)

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol
por: Nakamura, Kayo, et al.
Publicado: (2023)

Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains
por: Hodille, Elisabeth, et al.
Publicado: (2018)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
por: Bahraminia, F., et al.
Publicado: (2021)

Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid
por: de Vos, Margaretha, et al.
Publicado: (2021)

Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

A Novel marRAB Operon Contributes to the Rifampicin Resistance in Mycobacterium smegmatis
por: Zhang, Haiwei, et al.
Publicado: (2014)

Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people’s Republic of China
por: Yu, Meiwen, et al.
Publicado: (2013)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis
por: Feyisa, Seifu Gizaw, et al.
Publicado: (2019)

LipF increases rifampicin and streptomycin sensitivity in a Mycobacterium tuberculosis surrogate
por: Arriaga-Guerrero, Ana Leticia, et al.
Publicado: (2020)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gruo2elf06fduas2o00749p64f